Search research articles
Contact Us
Filters
Showing results (261-270 of 289) with videos related to
Page
of 29
Sort By:
Oncogene
|
October 5, 2021
RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNA
C James Block, Allison V Mitchell, Ling Wu, et al.
Scientific Reports
|
January 20, 2019
Disulfiram and BKM120 in Combination with Chemotherapy Impede Tumor Progression and Delay Tumor Recurrence in Tumor Initiating Cell-Rich TNBC
Ling Wu, Fanyan Meng, Lun Dong, et al.
Neuroimage. Clinical
|
February 15, 2021
Emotion regulation in emerging adults with major depressive disorder and frequent cannabis use
Emily S Nichols, Jacob Penner, Kristen A Ford, et al.
Journal - Association of Official Analytical Chemists
|
January 1, 1984
Protein efficiency ratio: AACC/ASTM collaborative study
L R Hackler, C E Bodwell, M L Happich, et al.
Journal - Association of Official Analytical Chemists
|
March 1, 1984
Net protein ratio data: AACC-ASTM collaborative study
M L Happich, C E Bodwell, L R Hackler, et al.
Biorxiv : the Preprint Server for Biology
|
June 26, 2025
A whole genomic CRISPR-Cas9 screen identifies the amino acid transporter <i>SLC43A1</i> (LAT3) as a major determinant of oxaliplatin sensitivity in colorectal cancer cells
N R Pawar, H M Wade, Z Jackson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 1998
Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: a randomized, crossover comparison
G C Toner, J D Shapiro, C R Laidlaw, et al.
The American Journal of Psychiatry
|
February 19, 2008
Reduced amygdala response to fearful expressions in children and adolescents with callous-unemotional traits and disruptive behavior disorders
Abigail A Marsh, Elizabeth C Finger, Derek G V Mitchell, et al.
Molecular Cancer Therapeutics
|
June 2, 2026
A whole genomic CRISPR-Cas9 screen identifies the amino acid transporter SLC43A1 (LAT3) as a major determinant of oxaliplatin sensitivity in colorectal cancer cells
Nisha R Pawar, Heidi M Wade, Zoe Jackson, et al.
JCI Insight
|
February 10, 2026
CD9 regulates macrophage-mediated remodeling of adipose tissue in obesity
Julia Chini, Nicole DeMarco, Dana V Mitchell, et al.
Page
of 29
Search research articles
Search
Showing results (261-270 of 289) with videos related to
Sort By:
Page
of 29
Oncogene
|
October 5, 2021
RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNA
C James Block, Allison V Mitchell, Ling Wu, et al.
Scientific Reports
|
January 20, 2019
Disulfiram and BKM120 in Combination with Chemotherapy Impede Tumor Progression and Delay Tumor Recurrence in Tumor Initiating Cell-Rich TNBC
Ling Wu, Fanyan Meng, Lun Dong, et al.
Neuroimage. Clinical
|
February 15, 2021
Emotion regulation in emerging adults with major depressive disorder and frequent cannabis use
Emily S Nichols, Jacob Penner, Kristen A Ford, et al.
Journal - Association of Official Analytical Chemists
|
January 1, 1984
Protein efficiency ratio: AACC/ASTM collaborative study
L R Hackler, C E Bodwell, M L Happich, et al.
Journal - Association of Official Analytical Chemists
|
March 1, 1984
Net protein ratio data: AACC-ASTM collaborative study
M L Happich, C E Bodwell, L R Hackler, et al.
Biorxiv : the Preprint Server for Biology
|
June 26, 2025
A whole genomic CRISPR-Cas9 screen identifies the amino acid transporter <i>SLC43A1</i> (LAT3) as a major determinant of oxaliplatin sensitivity in colorectal cancer cells
N R Pawar, H M Wade, Z Jackson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 1998
Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: a randomized, crossover comparison
G C Toner, J D Shapiro, C R Laidlaw, et al.
The American Journal of Psychiatry
|
February 19, 2008
Reduced amygdala response to fearful expressions in children and adolescents with callous-unemotional traits and disruptive behavior disorders
Abigail A Marsh, Elizabeth C Finger, Derek G V Mitchell, et al.
Molecular Cancer Therapeutics
|
June 2, 2026
A whole genomic CRISPR-Cas9 screen identifies the amino acid transporter SLC43A1 (LAT3) as a major determinant of oxaliplatin sensitivity in colorectal cancer cells
Nisha R Pawar, Heidi M Wade, Zoe Jackson, et al.
JCI Insight
|
February 10, 2026
CD9 regulates macrophage-mediated remodeling of adipose tissue in obesity
Julia Chini, Nicole DeMarco, Dana V Mitchell, et al.
Page
of 29